Functional glycans and glycoconjugates in human milk

American Journal of Clinical Nutrition

Volumn 98, Issue 2, 2013, Pages

  Georgi, Gilda ^a   Bartke, Nana ^a   Wiens, Frank ^a   Stahl, Bernd ^a  

^a Danone Research Centre for Specialised Nutrition   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; GLYCAN; GLYCOCONJUGATE; GLYCOLIPID; GLYCOPROTEIN; N ACETYLNEURAMINIC ACID; NERVE CELL ADHESION MOLECULE; OLIGOSACCHARIDE; SIALIC ACID DERIVATIVE;

ABSORPTION; ARTICLE; BREAST MILK; CARBOHYDRATE ANALYSIS; HUMAN; IMMUNE SYSTEM; INFANT NUTRITION; LACTATION; PROTEIN GLYCOSYLATION;

FEMALE; GLYCOCONJUGATES; GLYCOPROTEINS; HUMANS; IMMUNE SYSTEM; INFANT; LACTATION; MILK, HUMAN; NERVOUS SYSTEM; POLYSACCHARIDES;

EID: 84881228210     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.039065     Document Type: Article

References (151)

1. German JB, Freeman SL, Lebrilla CB, Mills DA. Human milk oligosaccharides: evolution, structures and bioselectivity as substrates for intestinal bacteria. Nestle Nutr Workshop Ser Pediatr Program 2008;62:205-18, discussion 218-22.
2. Engfer MB, Stahl B, Finke B, Sawatzki G, Daniel H. Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. Am J Clin Nutr 2000;71:1589-96.
3. Newburg DS. Do the binding properties of oligosaccharides in milk protect human infants from gastrointestinal bacteria? J Nutr 1997; 127:980S-4S.
4. Nizet V, Esko JD. Bacterial and viral infections. 2009.
5. McJarrow P, Schnell N, Jumpsen J, Clandinin T. Influence of dietary gangliosides on neonatal brain development. Nutr Rev 2009;67:451- 63.
6. Morgan BL, Winick M. The subcellular localization of administered N-acetylneuraminic acid in the brains of well-fed and protein restricted rats. Br J Nutr 1981;46:231-8.
7. Wang B, Yu B, Karim M, Hu H, Sun Y, McGreevy P, Petocz P, Held S, Brand-Miller J. Dietary sialic acid supplementation improves learning and memory in piglets. Am J Clin Nutr 2007;85: 561-9.
8. Duncan PI, Raymond F, Fuerholz A, Sprenger N. Sialic acid utilisation and synthesis in the neonatal rat revisited. PLoS ONE 2009;4: e8241.
9. Kitaoka M. Bifidobacterial enzymes involved in the metabolism of human milk oligosaccharides. Adv Nutr 2012;3:422S-9S.
10. Kiyohara M, Tanigawa K, Chaiwangsri T, Katayama T, Ashida H, Yamamoto K. An exo-alpha-sialidase from bifidobacteria involved in the degradation of sialyloligosaccharides in human milk and intestinal glycoconjugates. Glycobiology 2011;21:437-47.
11. LoCascio RG, Ninonuevo MR, Freeman SL, Sela DA, Grimm R, Lebrilla CB, Mills DA, German JB. Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation. J Agric Food Chem 2007;55:8914-9.
12. Sela DA, Li Y, Lerno L, Wu S, Marcobal AM, German JB, Chen X, Lebrilla CB, Mills DA. An infant-associated bacterial commensal utilizes breast milk sialyloligosaccharides. J Biol Chem 2011;286: 11909-18.
13. Ashida H, Miyake A, Kiyohara M, Wada J, Yoshida E, Kumagai H, Katayama T, Yamamoto K. Two distinct alpha-L-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates. Glycobiology 2009;19: 1010-7.
14. Dethlefsen L, Eckburg PB, Bik EM, Relman DA. Assembly of the human intestinal microbiota. Trends Ecol Evol 2006;21:517-23.
15. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9:313-23.
16. Zivkovic AM, German JB, Lebrilla CB, Mills DA. Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc Natl Acad Sci USA 2011;108(suppl 1):4653-8.
17. Eiwegger T, Stahl B, Haidl P, Schmitt J, Boehm G, Dehlink E, Urbanek R, Szepfalusi Z. Prebiotic oligosaccharides: in vitro evidence for gastrointestinal epithelial transfer and immunomodulatory properties. Pediatr Allergy Immunol 2010;21:1179-88.
18. Rudloff S, Pohlentz G, Diekmann L, Egge H, Kunz C. Urinary excretion of lactose and oligosaccharides in preterm infants fed human milk or infant formula. Acta Paediatr 1996;85:598-603.
19. Obermeier S, Rudloff S, Pohlentz G, Lentze MJ, Kunz C. Secretion of 13C-labelled oligosaccharides into human milk and infant's urine after an oral [13C]galactose load. Isotopes Environ Health Stud 1999; 35:119-25.
20. Rudloff S, Stefan C, Pohlentz G, Kunz C. Detection of ligands for selectins in the oligosaccharide fraction of human milk. Eur J Nutr 2002;41:85-92.
21. Bode L. Recent advances on structure, metabolism, and function of human milk oligosaccharides. J Nutr 2006;136:2127-30.
22. Schumacher G, Bendas G, Stahl B, Beermann C. Human milk oligosaccharides affect P-selectin binding capacities: in vitro investigation. Nutrition 2006;22:620-7.
23. Eiwegger T, Stahl B, Schmitt J, Boehm G, Gerstmayr M, Pichler J, Dehlink E, Loibichler C, Urbanek R, Szepfalusi Z. Human milk- derived oligosaccharides and plant-derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro. Pediatr Res 2004; 56:536-40.
24. Velupillai P, Harn DA. Oligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: a mechanism for regulation of CD4+ T-cell subsets. Proc Natl Acad Sci USA 1994;91:18-22.
25. Kunz C, Rudloff S, Baier W, Klein N, Strobel S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr 2000;20:699-722.
26. Urashima T, Asakuma S, Leo F, Fukuda K, Messer M, Oftedal OT. The predominance of type I oligosaccharides is a feature specific to human breast milk. Adv Nutr 2012;3:473S-82S.
27. Tao N, DePeters EJ, Freeman S, German JB, Grimm R, Lebrilla CB. Bovine milk glycome. J Dairy Sci 2008;91:3768-78.
28. Tao N, DePeters EJ, German JB, Grimm R, Lebrilla CB. Variations in bovine milk oligosaccharides during early and middle lactation stages analyzed by high-performance liquid chromatography-chip/mass spectrometry. J Dairy Sci 2009;92:2991-3001.
29. Ninonuevo MR, Park Y, Yin H, Zhang J, Ward RE, Clowers BH, German JB, Freeman SL, Killeen K, Grimm R, et al. A strategy for annotating the human milk glycome. J Agric Food Chem 2006;54: 7471-80.
30. Boehm G, Stahl B. Oligosaccharides. In: Mattila-Sandholm T, ed. Functional dairy products. Cambridge, United Kingdom: Woodhead Publishers, 2003:203-43.
31. Kobata A. Milk glycoproteins and oligosaccharides. In: Horowith M, Pigman W, eds. The glycoconjugates. Vol 1. New York, NY: Academic Press, 1977:423-40.
32. Stahl B, Thurl S, Zeng J, Karas M, Hillenkamp F, Steup M, Sawatzki G. Oligosaccharides from human milk as revealed by matrix-assisted laser desorption/ionization mass spectrometry. Anal Biochem 1994; 223:218-26.
33. Boehm G, Stahl B. Oligosaccharides from milk. J Nutr 2007;137 (suppl):847S-9S.
34. Varki A. Loss of N-glycolylneuraminic acid in humans: mechanisms, consequences, and implications for hominid evolution. Yearb Phys Anthropol 2001;44:54-69.
35. Simon PM, Goode PL, Mobasseri A, Zopf D. Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides. Infect Immun 1997;65:750-7.
36. Morrow AL, Rangel JM. Human milk protection against infectious diarrhea: implications for prevention and clinical care. Semin Pediatr Infect Dis 2004;15:221-8.
37. Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavez-Munguia B, Newburg DS. Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J Biol Chem 2003;278: 14112-20.
38. Humphrey T, O'Brien S, Madsen M. Campylobacters as zoonotic pathogens: a food production perspective. Int J Food Microbiol 2007; 117:237-57.
39. Wang B, Miller JB, McNeil Y, McVeagh P. Sialic acid concentration of brain gangliosides: variation among eight mammalian species. Comp Biochem Physiol A Mol Integr Physiol 1998;119:435-9.
40. Thurl S, Munzert M, Henker J, Boehm G, Muller-Werner B, Jelinek J, Stahl B. Variation of human milk oligosaccharides in relation to milk groups and lactational periods. Br J Nutr 2010;104:1261-71.
41. Asakuma S, Urashima T, Akahori M, Obayashi H, Nakamura T, Kimura K, Watanabe Y, Arai I, Sanai Y. Variation of major neutral oligosaccharides levels in human colostrum. Eur J Clin Nutr 2008;62: 488-94.
42. Erney RM, Malone WT, Skelding MB, Marcon AA, Kleman-Leyer KM, O'Ryan ML, Ruiz-Palacios G, Hilty MD, Pickering LK, Prieto PA. Variability of human milk neutral oligosaccharides in a diverse population. J Pediatr Gastroenterol Nutr 2000;30:181-92.
43. Thurl S, Henker J, Siegel M, Tovar K, Sawatzki G. Detection of four human milk groups with respect to Lewis blood group dependent oligosaccharides. Glycoconj J 1997;14:795-9.
44. Kobata A. The third chains of living organisms- A trail of glycobiology that started from the third floor of building 4 in NIH. Arch Biochem Biophys 2004;426:107-21.
45. Kobata A. Structures and application of oligosaccharides in human milk. Proc Jpn Acad, Ser B, Phys Biol Sci 2010;86:731-47.
46. Nishihara S, Narimatsu H, Iwasaki H, Yazawa S, Akamatsu S, Ando T, Seno T, Narimatsu I. Molecular genetic analysis of the human Lewis histo-blood group system. J Biol Chem 1994;269:29271-8.
47. Koda Y, Soejima M, Liu Y, Kimura H. Molecular basis for secretor type alpha(1,2)-fucosyltransferase gene deficiency in a Japanese population: a fusion gene generated by unequal crossover responsible for the enzyme deficiency. Am J Hum Genet 1996;59:343-50.
48. Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB. Sequence and expression of a candidate for the human secretor blood group alpha (1,2)fucosyltransferase gene (FUT2): homozygosity for an enzymeinactivating nonsense mutation commonly correlates with the nonsecretor phenotype. J Biol Chem 1995;270:4640-9.
49. Chaturvedi P, Warren CD, Altaye M, Morrow AL, Ruiz-Palacios G, Pickering LK, Newburg DS. Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. Glycobiology 2001;11:365-72.
50. Gabrielli O, Zampini L, Galeazzi T, Padella L, Santoro L, Peila C, Giuliani F, Bertino E, Fabris C, Coppa GV. Preterm milk oligosaccharides during the first month of lactation. Pediatrics 2011;128: e1520-31.
51. Morrow AL, Meinzen-Derr J, Huang P, Schibler KR, Cahill T, Keddache M, Kallapur SG, Newburg DS, Tabangin M, Warner BB, et al. Fucosyltransferase 2 non-secretor and low secretor status predicts severe outcomes in premature infants. J Pediatr 2011;158:745- 51.
52. Ikehara Y, Nishihara S, Yasutomi H, Kitamura T, Matsuo K, Shimizu N, Inada K-i, Kodera Y, Yamamura Y, Narimatsu H, et al. Polymorphisms of two fucosyltransferase genes (Lewis and secretor genes) involving type I Lewis antigens are associated with the presence of anti-Helicobacter pylori IgG antibody. Cancer Epidemiol Biomarkers Prev 2001;10:971-7.
53. Le Pendu J. Histo-blood group antigen and human milk oligosaccharides: genetic polymorphism and risk of infectious diseases. Adv Exp Med Biol 2004;554:135-43.
54. Anstee DJ. The relationship between blood groups and disease. Blood 2010;115:4635-43.
55. Thorven M, Grahn A, Hedlund KO, Johansson H, Wahlfrid C, Larson G, Svensson L. A homozygous nonsense mutation (428G/A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J Virol 2005;79:15351-5.
56. Bucardo F, Kindberg E, Paniagua M, Grahn A, Larson G, Vildevall M, Svensson L. Genetic susceptibility to symptomatic norovirus infection in Nicaragua. J Med Virol 2009;81:728-35. (Published erratum appears in J Med Virol 2009;81:1129.)
57. Sheinfeld J, Schaeffer AJ, Cordon-Cardo C, Rogatko A, Fair WR. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N Engl J Med 1989;320:773-7.
58. Blackwell CC, Jonsdottir K, Hanson MF, Weir DM. Non-secretion of ABO blood group antigens predisposing to infection by Haemophilus influenzae. Lancet 1986;2:687.
59. Newburg DS, Ruiz-Palacios GM, Morrow AL. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 2005;25: 37-58.
60. Musumeci M, Simpore J, D'Agata A, Sotgiu S, Musumeci S. Oligosaccharides in colostrum of Italian and Burkinabe women. J Pediatr Gastroenterol Nutr 2006;43:372-8.
61. Asakuma S, Akahori M, Kimura K, Watanabe Y, Nakamura T, Tsunemi M, Arai I, Sanai Y, Urashima T. Sialyl oligosaccharides of human colostrum: changes in concentration during the first three days of lactation. Biosci Biotechnol Biochem 2007;71:1447-51.
62. Martín-Sosa S, Martin MJ, Garcia-Pardo LA, Hueso P. Distribution of sialic acids in the milk of Spanish mothers of full term infants during lactation. J Pediatr Gastroenterol Nutr 2004;39:499-503.
63. Lee H, An HJ, Lerno LA Jr, German JB, Lebrilla CB. Rapid profiling of bovine and human milk gangliosides by matrix-assisted laser desorption/ ionization Fourier transform ion cyclotron resonance mass spectrometry. Int J Mass Spectrom 2011;305:138-50.
64. Jensen RG. Lipids in human milk. Lipids 1999;34:1243-71.
65. Jensen RG, Bitman J, Carlson SE, Couch SC, Hamosh M, Newburg DS. Human milk lipids. In: Jensen RG, ed. The handbook of milk composition. San Diego, CA: Academic Press, 1995:495-542.
66. Rueda R. The role of dietary gangliosides on immunity and the prevention of infection. Br J Nutr 2007;98(suppl 1):S68-73.
67. German JB, Dillard CJ. Composition, structure and absorption of milk lipids: a source of energy, fat-soluble nutrients and bioactive molecules. Crit Rev Food Sci Nutr 2006;46:57-92.
68. Lopez C, Menard O. Human milk fat globules: polar lipid composition and in situ structural investigations revealing the heterogeneous distribution of proteins and the lateral segregation of sphingomyelin in the biological membrane. Colloids Surf B Biointerfaces 2011;83: 29-41.
69. Martín-Sosa S, Martin MJ, Castro MD, Cabezas JA, Hueso P. Lactational changes in the fatty acid composition of human milk gangliosides. Lipids 2004;39:111-6.
70. Pan XL, Izumi T. Variation of the ganglioside compositions of human milk, cow's milk and infant formulas. Early Hum Dev 2000;57:25- 31.
71. Carlson SE. Early determinants of development: a lipid perspective. Am J Clin Nutr 2009;89(suppl):1523S-9S.
72. Birecki CJ, Drozdowski LA, Suh M, Park EJ, Clandinin MT, Thomson AB. Dietary gangliosides enhance in vitro lipid uptake in weanling rats. J Pediatr Gastroenterol Nutr 2006;42:59-65.
73. Drozdowski LA, Suh M, Park E, Clandinin MT, Thomson AB. Dietary gangliosides enhance in vitro glucose uptake in weanling rats. JPEN J Parenter Enteral Nutr 2007;31:423-9.
74. Rueda R, Maldonado J, Narbona E, Gil A. Neonatal dietary gangliosides. Early Hum Dev 1998;53(suppl):S135-47.
75. Schnabl KL, Larsen B, Van Aerde JE, Lees G, Evans M, Belosevic M, Field C, Thomson AB, Clandinin MT. Gangliosides protect bowel in an infant model of necrotizing enterocolitis by suppressing proinflammatory signals. J Pediatr Gastroenterol Nutr 2009;49:382-92.
76. Park EJ, Suh M, Ramanujam K, Steiner K, Begg D, Clandinin MT. Diet-induced changes in membrane gangliosides in rat intestinal mucosa, plasma and brain. J Pediatr Gastroenterol Nutr 2005;40:487- 95.
77. Pan XL, Izumi T. Chronological changes in the ganglioside composition of human milk during lactation. Early Hum Dev 1999;55: 1-8.
78. Rueda R, Sabatel JL, Maldonado J, Molina-Font JA, Gil A. Addition of gangliosides to an adapted milk formula modifies levels of fecal Escherichia coli in preterm newborn infants. J Pediatr 1998;133:90-4.
79. Takamizawa K, Iwamori M, Mutai M, Nagai Y. Selective changes in gangliosides of human milk during lactation: a molecular indicator for the period of lactation. Biochim Biophys Acta 1986;879:73-7.
80. Wang B, Brand-Miller J, McVeagh P, Petocz P. Concentration and distribution of sialic acid in human milk and infant formulas. Am J Clin Nutr 2001;74:510-5.
81. Rueda R, Puente R, Hueso P, Maldonado J, Gil A. New data on content and distribution of gangliosides in human milk. Biol Chem Hoppe Seyler 1995;376:723-7.
82. Sala-Vila A, Castellote AI, Rodriguez-Palmero M, Campoy C, Lopez- Sabater MC. Lipid composition in human breast milk from Granada (Spain): changes during lactation. Nutrition 2005;21:467-73.
83. Nakano T, Sugawara M, Kawakami H. Sialic acid in human milk: composition and functions. Acta Paediatr Taiwan 2001;42:11-7.
84. Pan X, Hua T, Wu Y. [Detection of gangliosides in human milk with a high performance thin layer chromatography (HPTLC).] Zhonghua Yu Fang Yi Xue Za Zhi 2001;35:111-3 (in Chinese).
85. Uchiyama S, Sekiguchi K, Akaishi M, Anan A, Maeda T, Izumi T. Characterization and chronological changes of preterm human milk gangliosides. Nutrition 2011;27:998-1001.
86. Brønnum H, Seested T, Hellgren LI, Brix S, Frokiaer H. Milk-derived GM(3) and GD(3) differentially inhibit dendritic cell maturation and effector functionalities. Scand J Immunol 2005;61:551-7.
87. Idota T, Kawakami H. Inhibitory effects of milk gangliosides on the adhesion of Escherichia coli to human intestinal carcinoma cells. Biosci Biotechnol Biochem 1995;59:69-72.
88. Otnaess AB, Laegreid A, Ertresvag K. Inhibition of enterotoxin from Escherichia coli and Vibrio cholerae by gangliosides from human milk. Infect Immun 1983;40:563-9.
89. Sánchez-Juanes F, Alonso JM, Zancada L, Hueso P. Glycosphingolipids from bovine milk and milk fat globule membranes: a comparative study. Adhesion to enterotoxigenic Escherichia coli strains. Biol Chem 2009;390:31-40.
90. Laegreid A, Kolsto Otnaess AB. Trace amounts of ganglioside GM1 in human milk inhibit enterotoxins from Vibrio cholerae and Escherichia coli. Life Sci 1987;40:55-62.
91. Herrera-Insua I, Gomez HF, Diaz-Gonzalez VA, Chaturvedi P, Newburg DS, Cleary TG. Human milk lipids bind Shiga toxin. Adv Exp Med Biol 2001;501:333-9.
92. Iwamori M, Takamizawa K, Momoeda M, Iwamori Y, Taketani Y. Gangliosides in human, cow and goat milk, and their abilities as to neutralization of cholera toxin and botulinum type A neurotoxin. Glycoconj J 2008;25:675-83.
93. Wada A, Hasegawa M,Wong PF, Shirai E, Shirai N, Tan LJ, Llanes R, Hojo H, Yamasaki E, Ichinose A, et al. Direct binding of gangliosides to Helicobacter pylori vacuolating cytotoxin (VacA) neutralizes its toxin activity. Glycobiology 2010;20:668-78.
94. Rolsma MD, Kuhlenschmidt TB, Gelberg HB, Kuhlenschmidt MS. Structure and function of a ganglioside receptor for porcine rotavirus. J Virol 1998;72:9079-91.
95. Viveros-Rogel M, Soto-Ramirez L, Chaturvedi P, Newburg DS, Ruiz-Palacios GM. Inhibition of HIV-1 infection in vitro by human milk sulfated glycolipids and glycosaminoglycans. Adv Exp Med Biol 2004;554:481-7.
96. Suzuki Y, Nakao T, Ito T, Watanabe N, Toda Y, Xu G, Suzuki T, Kobayashi T, Kimura Y, Yamada A, et al. Structural determination of gangliosides that bind to influenza A, B, and C viruses by an improved binding assay: strain-specific receptor epitopes in sialo-sugar chains. Virology 1992;189:121-31.
97. Terabayashi T, Morita M, Ueno M, Nakamura T, Urashima T. Inhibition of influenza-virus-induced cytopathy by sialylglycoconjugates. Carbohydr Res 2006;341:2246-53.
98. Suh M, Belosevic M, Clandinin MT. Dietary lipids containing gangliosides reduce Giardia muris infection in vivo and survival of Giardia lamblia trophozoites in vitro. Parasitology 2004;128:595- 602.
99. Wang B. Sialic acid is an essential nutrient for brain development and cognition. Annu Rev Nutr 2009;29:177-222.
100. Wang B, Brand-Miller J. The role and potential of sialic acid in human nutrition. Eur J Clin Nutr 2003;57:1351-69.
101. Wang B, McVeagh P, Petocz P, Brand-Miller J. Brain ganglioside and glycoprotein sialic acid in breastfed compared with formula-fed infants. Am J Clin Nutr 2003;78:1024-9.
102. Lönnerdal B. Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr 2003;77(suppl):1537S-43S.
103. van Veen HA, Geerts ME, van Berkel PH, Nuijens JH. The role of N-linked glycosylation in the protection of human and bovine lactoferrin against tryptic proteolysis. Eur J Biochem 2004;271:678- 84.
104. van Berkel PH, Geerts ME, van Veen HA, Kooiman PM, Pieper FR, de Boer HA, Nuijens JH. Glycosylated and unglycosylated human lactoferrins both bind iron and show identical affinities towards human lysozyme and bacterial lipopolysaccharide, but differ in their susceptibilities towards tryptic proteolysis. Biochem J 1995;312: 107-14.
105. Davidson LA, Lonnerdal B. Persistence of human milk proteins in the breast-fed infant. Acta Paediatr Scand 1987;76:733-40.
106. Yolken RH, Peterson JA, Vonderfecht SL, Fouts ET, Midthun K, Newburg DS. Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. J Clin Invest 1992;90:1984-91.
107. Dallas DC, Sela D, Underwood MA, German JB, Lebrilla CB. Protein-linked glycan degradation in infants fed human milk. J Glycomics Lipidomics 2012;S1:002.
108. Charlwood J, Hanrahan S, Tyldesley R, Langridge J, Dwek M, Camilleri P. Use of proteomic methodology for the characterization of human milk fat globular membrane proteins. Anal Biochem 2002; 301:314-24.
109. Froehlich JW, Dodds ED, Barboza M, McJimpsey EL, Seipert RR, Francis J, An HJ, Freeman S, German JB, Lebrilla CB. Glycoprotein expression in human milk during lactation. J Agric Food Chem 2010; 58:6440-8.
110. Picariello G, Ferranti P, Mamone G, Roepstorff P, Addeo F. Identification of N-linked glycoproteins in human milk by hydrophilic interaction liquid chromatography and mass spectrometry. Proteomics 2008;8:3833-47.
111. Kanwar JR, Kanwar RK, Sun X, Punj V, Matta H, Morley SM, Parratt A, Puri M, Sehgal R. Molecular and biotechnological advances in milk proteins in relation to human health. Curr Protein Pept Sci 2009; 10:308-38.
112. Potocnik K, Gantner V, Kuterovac K, Cividini A. Mare's milk: composition and protein fraction in comparison with different milk species. Mljekarstvo 2011;61:107-13.
113. Nwosu CC, Aldredge DL, Lee H, Lerno LA, Zivkovic AM, German JB, Lebrilla CB. Comparison of the human and bovine milk Nglycome via high-performance microfluidic chip liquid chromatography and tandem mass spectrometry. J Proteome Res 2012;11:2912-24.
114. Moro G, Minoli I, Boehm G, Georgi G, Jelinek J, Sawatzki G. Postprandial plasma amino acids in preterm infants: influence of the protein source. Acta Paediatr 1999;88:885-9.
115. Renkonen O. Enzymatic in vitro synthesis of I-branches of mammalian polylactosamines: generation of scaffolds for multiple selectin-binding saccharide determinants. Cell Mol Life Sci 2000;57: 1423-39.
116. Ma B, Simala-Grant JL, Taylor DE. Fucosylation in prokaryotes and eukaryotes. Glycobiology 2006;16:158R-84R.
117. Garrido D, Kim JH, German JB, Raybould HE, Mills DA. Oligosaccharide binding proteins from Bifidobacterium longum subsp. infantis reveal a preference for host glycans. PLoS ONE 2011;6: e17315.
118. Peterson JA, Hamosh M, Scallan CD, Ceriani RL, Henderson TR, Mehta NR, Armand M, Hamosh P. Milk fat globule glycoproteins in human milk and in gastric aspirates of mother's milk-fed preterm infants. Pediatr Res 1998;44:499-506.
119. Kanyshkova TG, Babina SE, Semenov DV, Isaeva N, Vlassov AV, Neustroev KN, Kul'minskaya AA, Buneva VN, Nevinsky GA. Multiple enzymic activities of human milk lactoferrin. Eur J Biochem 2003;270:3353-61.
120. Suzuki YA, Shin K, Lonnerdal B. Molecular cloning and functional expression of a human intestinal lactoferrin receptor. Biochemistry 2001;40:15771-9.
121. Davidsson L, Kastenmayer P, Yuen M, Lonnerdal B, Hurrell RF. Influence of lactoferrin on iron absorption from human milk in infants. Pediatr Res 1994;35:117-24.
122. Lönnerdal B. Nutritional roles of lactoferrin. Curr Opin Clin Nutr Metab Care 2009;12:293-7.
123. Newburg DS. Innate immunity and human milk. J Nutr 2005;135: 1308-12.
124. Palmer DJ, Kelly VC, Smit AM, Kuy S, Knight CG, Cooper GJ. Human colostrum: identification of minor proteins in the aqueous phase by proteomics. Proteomics 2006;6:2208-16.
125. Tomita M, Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J Dairy Sci 1991;74:4137-42.
126. Chaturvedi P, Singh AP, Batra SK. Structure, evolution, and biology of the MUC4 mucin. FASEB J 2008;22:966-81.
127. Newburg DS. Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J Anim Sci 2009;87:26-34.
128. Lönnerdal B. Biological effects of novel bovine milk fractions. Nestle Nutr Workshop Ser Pediatr Program 2011;67:41-54.
129. Yamauchi K, Wakabayashi H, Shin K, Takase M. Bovine lactoferrin: benefits and mechanism of action against infections. Biochem Cell Biol 2006;84:291-6.
130. Krissansen GW. Emerging health properties of whey proteins and their clinical implications. J Am Coll Nutr 2007;26:713S-23S.
131. Lombardo D. Bile salt-dependent lipase: its pathophysiological implications. Biochim Biophys Acta 2001;1533:1-28.
132. Wheeler TT, Hodgkinson AJ, Prosser CG, Davis SR. Immune components of colostrum and milk- A historical perspective. J Mammary Gland Biol Neoplasia 2007;12:237-47.
133. Sodek J, Ganss B, McKee MD. Osteopontin. Crit Rev Oral Biol Med 2000;11:279-303.
134. Andersson Y, Hammarstrom ML, Lonnerdal B, Graverholt G, Falt H, Hernell O. Formula feeding skews immune cell composition toward adaptive immunity compared to breastfeeding. J Immunol 2009;183: 4322-8.
135. Standal T, Borset M, Sundan A. Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol 2004;26: 179-84.
136. Sandström O, Lönnerdal B, Graverholt G, Hernell O. Effects of a-lactalbumin-enriched formula containing different concentrations of glycomacropeptide on infant nutrition. Am J Clin Nutr 2008;87: 921-8.
137. Saarinen UM, Siimes MA, Dallman PR. Iron absorption in infants: high bioavailability of breast milk iron as indicated by the extrinsic tag method of iron absorption and by the concentration of serum ferritin. J Pediatr 1977;91:36-9.
138. Lindquist S, Hernell O. Lipid digestion and absorption in early life: an update. Curr Opin Clin Nutr Metab Care 2010;13:314-20.
139. Gross SJ, Buckley RH, Wakil SS, McAllister DC, David RJ, Faix RG. Elevated IgA concentration in milk produced by mothers delivered of preterm infants. J Pediatr 1981;99:389-93.
140. Walker A. Breast milk as the gold standard for protective nutrients. J Pediatr 2010;156:S3-7.
141. Cheng JB, Wang JQ, Bu DP, Liu GL, Zhang CG, Wei HY, Zhou LY, Wang JZ. Factors affecting the lactoferrin concentration in bovine milk. J Dairy Sci 2008;91:970-6.
142. Mehta R, Petrova A. Biologically active breast milk proteins in association with very preterm delivery and stage of lactation. J Perinatol 2011;31:58-62.
143. Shin K, Tomita M, Lonnerdal B. Identification of lactoperoxidase in mature human milk. J Nutr Biochem 2000;11:94-102.
144. Schack L, Lange A, Kelsen J, Agnholt J, Christensen B, Petersen TE, Sorensen ES. Considerable variation in the concentration of osteopontin in human milk, bovine milk, and infant formulas. J Dairy Sci 2009;92:5378-85.
145. Liao Y, Alvarado R, Phinney B, Lonnerdal B. Proteomic characterization of human milk fat globule membrane proteins during a 12 month lactation period. J Proteome Res 2011;10:3530-41.
146. Giuffrida MG, Cavaletto M, Giunta C, Neuteboom B, Cantisani A, Napolitano L, Calderone V, Godovac-Zimmermann J, Conti A. The unusual amino acid triplet Asn-Ile-Cys is a glycosylation consensus site in human alpha-lactalbumin. J Protein Chem 1997;16:747-53.
147. Landberg E, Huang Y, Stromqvist M, Mechref Y, Hansson L, Lundblad A, Novotny MV, Pahlsson P. Changes in glycosylation of human bile-salt-stimulated lipase during lactation. Arch Biochem Biophys 2000;377:246-54.
148. Ruvoën-Clouet N, Mas E, Marionneau S, Guillon P, Lombardo D, Le Pendu J. Bile-salt-stimulated lipase and mucins from milk of 'secretor' mothers inhibit the binding of Norwalk virus capsids to their carbohydrate ligands. Biochem J 2006;393:627-34.
149. Barboza M, Pinzon J, Wickramasinghe S, Froehlich JW, Moeller I, Smilowitz JT, Ruhaak LR, Huang J, Lonnerdal B, German JB, et al. Glycosylation of human milk lactoferrin exhibits dynamic changes during early lactation enhancing its role in pathogenic bacteria-host interactions. Mol Cell Proteomics 2012;11:M111.015248.
150. Dallas DC, Martin WF, Strum JS, Zivkovic AM, Smilowitz JT, Underwood MA, Affolter M, Lebrilla CB, German JB. N-linked glycan profiling of mature human milk by high-performance microfluidic chip liquid chromatography time-of-flight tandem mass spectrometry. J Agric Food Chem 2011;59:4255-63.
151. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993;3:97-130.